JUHE:XETRA:XETRA-JPMorgan ETFs (Ireland) ICAV - US Research Enhanced Index Equity UCITS ETF - EUR Hedged (acc) (EUR)

ETF | Others |

Last Closing

USD 45.52

Change

0.00 (0.00)%

Market Cap

N/A

Volume

921.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.31 (+0.60%)

USD 577.24B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.51%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.17 (+0.61%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.17 (+0.60%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.02 (+0.06%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.02 (+0.04%)

USD 112.46B
8R80:XETRA Amundi Index Solutions - Amund..

+0.42 (+0.28%)

USD 112.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.29 (+0.56%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+0.86 (+0.16%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

+0.13 (+0.55%)

USD 79.79B

ETFs Containing JUHE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.75% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.75% 85% B 84% B
Trailing 12 Months  
Capital Gain 26.57% 83% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.57% 83% B 82% B
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.31% 72% C 70% C-
Dividend Return 9.31% 71% C- 68% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.38% 50% F 59% D-
Risk Adjusted Return 75.18% 86% B+ 87% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.